☰
Companies
▾
Companies
Calendar
Valuation
Screener
▾
Screener
Sectors
Magic Formula
Bubble Plot
Treemap
Chart Builder
Analysis
▾
Margins
Dividends
Buybacks
Countries
US vs EU P/E
IPO Tracker
Insider Buying
CEO Changes
M&A Tracker
Short Selling
Fear & Greed
AI Models
Macro
▾
EU Economy
US Economy
EU Jobs & Unemployment
US Jobs & Unemployment
EU Housing
US Housing
EU Government Debt
US Federal Debt
ECB Rates & Inflation
Fed Rates & Inflation
EU Yield Curve
US Yield Curve
Health
▾
Diabetes
Immunology
Portfolio
▾
Portfolio
Berkshire
Buffett
More
▾
Denmark
Danish Tax
Tesla
EU XBRL Tables
Contact
Obesity
Blog
ANI Pharmaceuticals Inc
ANIP
☆
Healthcare
·
USA
·
USD
·
anipharmaceuticals.com
Fundamentals
Gross Margin
58.2%
Op. Margin
12.6%
Net Margin
8.9%
ROIC
7.8%
Rev Growth
43.8%
Valuation
Market Cap
1.8B USD
Fwd P/E
7.4x
EV/EBITDA
9.3x
Div Yield
-
Financial Data
#
Annual
Quarterly
TTM
Income Statement
Margins
Cash Flow
Balance Sheet
Dividends
Shares
Position
Liquidity
Share Count
Buybacks
Segment Breakdown
#
Multiples
#
P/S
EV/S
EV/EBITDA
P/E
1Y
2Y
5Y
10Y
All
Peers
#
PRGO
SUPN
PCRX
COLL
AMPH
SLDB
IRWD
AMRX
EOLS
ELAN
·
Compare in Screener
Dividends
Bubble
Gross Margin
Op. Margin
Net Margin
Fwd P/E
ROIC
Capex Intensity
Rev. Growth
Growth vs Margin
Revenue Mix
#
By Business Area
By Product
By Geography
Annual
Quarterly
TTM
Chief Executives
#
Events
#
All
Insider
Earnings
Dividends
Date
Type
Details
Price
Amount
See also:
Healthcare in Screener
Treemap - USA
USA in Screener